EMCORE Corporation to Report Fiscal Third Quarter 2017 Results on Thursday, August 3, 2017
Jul 27, 2017 20:05 pm UTC| Business
ALHAMBRA, Calif., July 27, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
Crocs, Inc. Announces Conference Call to Review Second Quarter Fiscal 2017 Results
Jul 27, 2017 20:05 pm UTC| Business
NIWOT, Colo., July 27, 2017 -- Crocs, Inc. (NASDAQ:CROX) today announced that on Wednesday August 9, 2017 at 8:30 a.m. ET, it will host a conference call to discuss the results of its second quarter ended June 30,...
STRATA Skin Sciences, Inc. to Report 2nd Quarter 2017 Financial Results on Thursday, August 10
Jul 27, 2017 20:05 pm UTC| Business
HORSHAM, Pa., July 27, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the...
Kamada Announces Proposed Public Offering of Ordinary Shares
Jul 27, 2017 20:05 pm UTC| Business
REHOVOT, Israel, July 27, 2017 -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that it intends to offer and sell its ordinary shares...
BJ’s Restaurants, Inc. Reports Fiscal 2017 Second Quarter Results
Jul 27, 2017 20:03 pm UTC| Business
HUNTINGTON BEACH, Calif., July 27, 2017 -- BJ’s Restaurants, Inc. (NASDAQ:BJRI) today reported financial results for its fiscal 2017 second quarter ended Tuesday, July 4, 2017. Second Quarter 2017 Highlights Compared...
Solid financials support R&D progress
Jul 27, 2017 20:02 pm UTC| Business
First half-year financial results: Revenues €73.0 M, an increase of €24.3 M compared to H1 2016 Operating loss €32.9 M, an increase of €8.6 M compared to H1 2016 Cash on 30 June 2017 of €1,263.2 M Raised...
Jul 27, 2017 20:02 pm UTC| Business
BURNABY, British Columbia, July 27, 2017 -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2017 second quarter financial and operating...